Literature DB >> 8957979

Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain.

L Arendt-Nielsen1, J Nielsen, S Petersen-Felix, T W Schnider, A M Zbinden.   

Abstract

We have compared the analgesic efficacy of the racemic mixture and the stereoisomer (S+) of the NMDA antagonist ketamine. In a double-blind, three-way crossover, placebo-controlled study, we assessed the following: pain evoked by small/large area pressure stimuli, pain detection threshold and pain ratings to small/large area of heat stimuli, pain detection threshold and pain rating to heat stimuli of brief/long duration, summation pain threshold and pain ratings to repeated heat/electrical stimuli, side effects and reaction time. Plasma concentrations of 350 ng ml-1 for ketamine (racemic) and 180 ng ml-1 for ketamine (S+) were tried. We found that ketamine (racemic) prolonged the reaction time more than ketamine (S+). Both drugs affected pain caused by repeated stimuli or stimuli of long duration equally or more than a single stimulus of short duration. They also affected pain evoked from large areas equally or more than pain evoked from small areas. The (S+)-isomer was approximately twice as potent as the racemic mixture of ketamine in inhibiting central summation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957979     DOI: 10.1093/bja/77.5.625

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  23 in total

1.  Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.

Authors:  Samuel Fanta; Mari Kinnunen; Janne T Backman; Eija Kalso
Journal:  Eur J Clin Pharmacol       Date:  2015-03-01       Impact factor: 2.953

2.  S-ketamine concentrations are greatly increased by grapefruit juice.

Authors:  Marko A Peltoniemi; Teijo I Saari; Nora M Hagelberg; Kari Laine; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2012-06       Impact factor: 2.953

3.  The effect of target-controlled infusion of low-dose ketamine on heat pain and temporal summation threshold.

Authors:  Joon-Ho Lee; Sung-Hwan Cho; Sang-Hyun Kim; Won-Soek Chae; Hee-Cheol Jin; Jeong-Seok Lee; Yong-Ik Kim
Journal:  J Anesth       Date:  2011-04-22       Impact factor: 2.078

4.  Physiological properties of the lamina I spinoparabrachial neurons in the mouse.

Authors:  Julien Allard
Journal:  J Physiol       Date:  2019-02-28       Impact factor: 5.182

5.  Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.

Authors:  M Knobloch; C J Portier; O L Levionnois; R Theurillat; W Thormann; C Spadavecchia; M Mevissen
Journal:  Toxicol Appl Pharmacol       Date:  2006-07-03       Impact factor: 4.219

Review 6.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

Review 7.  Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 8.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

9.  Rapid ultrasonic stimulation of inflamed tissue with diagnostic intent.

Authors:  Abbi M McClintic; Trevor C Dickey; Michael Gofeld; P Ray Illian; Michel Kliot; John C Kucewicz; John D Loeser; Philippe G Richebe; Pierre D Mourad
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

Review 10.  Analgo-sedation of patients with burns outside the operating room.

Authors:  Cesare Gregoretti; Daniela Decaroli; Quirino Piacevoli; Alice Mistretta; Nicoletta Barzaghi; Nicola Luxardo; Irene Tosetti; Luisa Tedeschi; Laura Burbi; Paolo Navalesi; Fabio Azzeri
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.